Review
doi: 10.1146/annurev.med.46.1.299.
Marrow transplantation for myeloma
Affiliations
- PMID: 7598466
- DOI: 10.1146/annurev.med.46.1.299
Item in Clipboard
Review
Marrow transplantation for myeloma
Annu Rev Med.
1995.
Abstract
High-dose therapy with hemopoietic stem cell support in multiple myeloma (MM) has been used for 10 years. This approach is currently the most promising form of treatment for this disease. We review here its rationale and the results of clinical trials according to the source of hematopoietic stem cells [allogeneic or autologous, bone marrow or blood]. Finally, we discuss the ongoing uncertainties regarding the utility of this treatment and the future prospects for high-dose therapy in MM.
Similar articles
-
The role of autologous stem cell transplantation in the management of multiple myeloma.Pathol Biol (Paris). 1999 Feb;47(2):199-202. Pathol Biol (Paris). 1999. PMID: 10192889 Review.
-
[Stem cell transplantation in multiple myeloma].Gan To Kagaku Ryoho. 1999 Sep;26(10):1407-14. Gan To Kagaku Ryoho. 1999. PMID: 10500527 Review. Japanese.
-
High-dose chemotherapy in multiple myeloma.Leukemia. 1997 Dec;11 Suppl 5:S27-31. Leukemia. 1997. PMID: 9436935 Review.
-
Treatment of multiple myeloma.Haematologica. 1999 Jan;84(1):36-58. Haematologica. 1999. PMID: 10091392 Review.
-
Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myeloma.Bone Marrow Transplant. 1995 Jun;15(6):963-9. Bone Marrow Transplant. 1995. PMID: 7581098 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
